The introduction of AT-III to the FXa chromogenic assay demonstrated that only APS-IgG significantly reduced the AT-III-mediated inhibition of FXa, whereas SLE-IgG and HC-IgG did not. This evidence concerns the gene SERPINC1 and systemic lupus erythematosus.